Nipro Corporation
Stock Price Chart
2026/08/21 UpdatedPrice Trend
2026/08/21 UpdatedPrice & Trading Details
2026/08/21 UpdatedPRICE
TRADING
Analyst Recommendations 5 analysts
Updated 2026/08/01Earnings Calendar
Updated 2026/08/01Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2026/05/12 | ¥-16.01 | ¥-19.50 | -21.8% |
| 2026/02/09 | ¥21.09 | ¥66.09 | +213.3% |
| 2025/11/10 | ¥22.44 | ¥16.15 | -28.0% |
| 2025/08/07 | ¥13.55 | ¥20.06 | +48.0% |
Shareholder Composition
Updated 2026/08/01Major Holders
Updated 2026/08/01| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
American Century ETF Trust-Avantis International Small Cap Value ETF
|
4.2M | +6.99% | |
|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
|
2.2M | +0.93% | |
|
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
|
1.5M | +0.57% | |
|
iShares Trust-iShares Core MSCI EAFE ETF
|
1.1M | 0.00% | |
|
DFA INVESTMENT DIMENSIONS GROUP INC-DFA Intl Small Cap Value PORT.
|
972.8K | +20.84% | |
|
DFA INVESTMENT DIMENSIONS GROUP INC-Intl Core Eqy. 2 PORT.
|
698.5K | +12.24% |
Dividend History
Updated 2026/08/23| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥19 | -17.4% |
| 2025 | ¥23 | -14.8% |
| 2024 | ¥27 | +45.9% |
| 2023 | ¥19 | -28.8% |
| 2022 | ¥26 | - |
Financial Performance
2026/08/23 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥494,789M | ¥545,199M | ¥586,785M | ¥644,586M |
| Gross Profit | ¥149,269M | ¥163,449M | ¥171,320M | ¥190,883M |
| Operating Income | ¥23,883M | ¥17,729M | ¥22,335M | ¥26,598M |
| Pretax Income | ¥27,378M | ¥21,278M | ¥25,746M | ¥26,931M |
| Net Income | ¥13,455M | ¥4,574M | ¥11,109M | ¥5,113M |
| EPS | ¥77.42 | ¥24.85 | ¥24.85 | ¥27.78 |
| Operating Margin | 4.83% | 3.25% | 3.81% | 4.13% |
| Balance Sheet | ||||
| Total Assets | ¥930,321M | ¥1,027,399M | ¥1,109,821M | ¥1,170,564M |
| Total Equity | ¥185,238M | ¥206,317M | ¥232,664M | ¥252,445M |
| Total Liabilities | ¥745,083M | ¥821,082M | ¥877,157M | ¥918,119M |
| Cash | ¥95,342M | ¥89,678M | ¥99,667M | ¥106,668M |
| Interest-bearing Debt | ¥564,852M | ¥605,931M | ¥635,687M | ¥636,873M |
| Equity Ratio | 19.91% | 20.08% | 20.96% | 21.57% |
| D/E Ratio | 3.05 | 2.94 | 2.73 | 2.52 |
| Cash Flow | ||||
| Operating CF | ¥68,214M | ¥10,395M | ¥72,936M | ¥68,461M |
| Investing CF | -¥78,434M | -¥71,737M | -¥87,075M | -¥71,876M |
| Financing CF | ¥10,297M | ¥43,077M | ¥22,142M | ¥5,376M |
| Free CF | ¥68,214M | ¥10,395M | ¥72,936M | ¥68,461M |
| Efficiency | ||||
| ROE | 7.26% | 2.22% | 4.77% | 2.03% |
| ROA | 1.45% | 0.45% | 1.00% | 0.44% |
Latest IR Information
-
[Nipro] Q1 Consolidated Financial Results for the Period Ending March 2027｜First Quarter
For the first quarter of the fiscal year ending March 2027, the consolidated results show net sales of 159,220 million yen, operating income of 7,212 million yen, ordinary income of 7,385 million yen, and net income attributable to owners of...
Read more -
【Nipro Group】Projected Capital Gains from Sale of Investment Securities ｜ July 2026
Nipro Group announced that it plans to sell the shares of Atnaorp Corporation, a target investment, and expects to recognize approximately 3,900 million yen as a special gain in the fiscal year ending March 2027.
Read more -
[Nipro] Subsidiary Sale and Business Restructuring | June 2026
Nipro resolved at its Board of Directors meeting on June 26, 2026, to transfer shares of the subsidiaries Gentuity and the equity-method affiliate Spryte, implementing a business restructuring. There will be no impact on consolidated performance, with transfer amounts approximately...
Read more -
Notice of Partial Amendment to Articles of Incorporation | June 26, 2026
Nipro Corporation announced that it plans to seek shareholder approval at the General Meeting of Shareholders on June 26, 2026, for a partial amendment to its Articles of Incorporation aimed at enhancing management flexibility.
Read more -
【Nipro Corporation】 FY2026 March Financial Results ｜ Forex Loss of ¥4,191 million, Subsidy Income Recognized of ¥4,073 million
Consolidated financial results for FY2026 show forex losses of ¥4,191 million and subsidy income of ¥4,073 million. Additionally, a fixed asset impairment loss of ¥3,870 million was recognized, impacting performance.
Read more -
【Nipro】2026 Financial Results | Net Sales of JPY 660.5 billion, Net Income of JPY 13.5 billion increased
Nipro achieved net sales of JPY 660.5 billion (YoY +2.5%) and net income of JPY 13.5 billion (YoY +164.1%) for the fiscal year ending March 2026, driven by expansion in overseas and healthcare-related businesses.
Read more
Latest News (5 items)
-
Average Analyst Rating: buy
Average Target Price: ¥1,986
Rating Score: 2.40 (Based on 5 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses. Its Medical-Related business develops, manufactures, and sells injection and infusion products, artificial organ-related products, functional products, dialysis products, cell cultures, hospital products, diabetic products, and pharmaceuticals comprising generic and kit products; and manufactures medical equipment, including dialysis medical device products; and operates dialysis and training centers. The company's Pharmaceutical-Related business engages in the contract manufacturing of pharmaceutical products with containers for combination products, including injectable kit products consigned by other pharmaceutical companies; and provides injectable, oral drugs products. In addition, its Pharma Packaging business offers pharmaceutical packaging containers and glass tubing, such as molded components for vials, syringes, rubber stoppers, and devices used to administer pharmaceuticals; and glass for thermos bottles, lighting and containers for combination products, glass equipment, as well glass for ampoules. Further, the company serves customers in Japan, the Americas, Europe, and rest of Asia. Nipro Corporation was founded in 1947 and is based in Settsu, Japan.
